Ionix Pharmaceuticals Company
A leader in the discovery and development of new analgesic medicines for the treatment of acute and chronic pain.
Last Funding Type:
Series A
Funding Status:
M&A
Headquarters:
Cambridge, Cambridgeshire, United Kingdom
Founded Date:
2001
Investor Type:
For Profit
Total Funding:
$11M
Technology:
Neurological Disorders
Employee Number:
101-250
Investors Number:
5
Industry:
PharmTech